Esperion Theraptc
(ESPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92,447 | 86,061 | 114,633 | 144,761 | 144,717 |
| Receivables | 118,980 | 107,746 | 81,294 | 80,142 | 67,824 |
| Inventories | 108,539 | 114,466 | 99,322 | 94,491 | 80,102 |
| Other current assets | 4,408 | 5,380 | 4,815 | 4,155 | 14,413 |
| TOTAL | $360,464 | $342,595 | $318,778 | $337,998 | $307,555 |
| Non-Current Assets | |||||
| PPE Net | 175 | 201 | 228 | 254 | 281 |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 3,325 | 4,233 | 4,967 | 5,513 | 6,222 |
| TOTAL | $3,556 | $4,490 | $5,251 | $5,823 | $6,559 |
| Total Assets | $364,020 | $347,085 | $324,029 | $343,821 | $314,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 77,513 | 74,704 | 71,994 | 51,650 | 34,864 |
| Accrued Expenses | 80,127 | 62,508 | 63,076 | 61,570 | 55,549 |
| Other current liabilities | 94,826 | 66,312 | 57,237 | 47,586 | 38,394 |
| TOTAL | $359,033 | $298,796 | $270,966 | $246,233 | $165,873 |
| Non-Current Liabilities | |||||
| Long Term Debt | 151,653 | 146,452 | 141,449 | 140,971 | N/A |
| Deferred Revenues | 30,679 | 22,313 | 4,542 | 8,518 | 15,078 |
| Other Non-Current Liabilities | 304,695 | 335,346 | 337,825 | 345,339 | 518,450 |
| TOTAL | $456,348 | $481,798 | $479,274 | $486,310 | $518,450 |
| Total Liabilities | $815,381 | $780,594 | $750,240 | $732,543 | $684,323 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 239,063 | 201,623 | 198,200 | 197,849 | 197,035 |
| Common Shares | 205 | 200 | 197 | 196 | 195 |
| Retained earnings | -1,685,542 | -1,654,209 | -1,641,484 | -1,601,029 | -1,579,711 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $-451,361 | $-433,509 | $-426,211 | $-388,722 | $-370,209 |
| Total Liabilities And Equity | $364,020 | $347,085 | $324,029 | $343,821 | $314,114 |